PMVP insider transaction filings
PMV Pharmaceuticals, Inc. — 25 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-05. Screen PMVP transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | FLOWERS KIRSTEN — Director | Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Stelzer Laurie — Director | Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | BAUM CHARLES M — Director | Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Gallagher Carol Giltner — Director | Grant/award (A): 42,000 (derivative) @ $0 · Gift (G): 42,000 (derivative) @ $0 · Gift (G): 42,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | LEVINE ARNOLD J — Director | Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Carulli Michael — Chief Financial Officer | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Jalota Deepika — Chief Development Officer | Grant/award (A): 303,310 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Ticktin Robert — General Counsel & COO | Grant/award (A): 319,270 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Mack David Henry — President and CEO, Director | Grant/award (A): 744,960 (derivative) @ $0 | EDGAR |
| 2025-10-29 | 4 | Mack David Henry — President and CEO, Director | Option exercise (M): 220,643 @ $1.37 · Option exercise (M): 220,643 (derivative) @ $0 | EDGAR |
| 2025-10-27 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Capital GP V LLC — 10% owner | Sale (S): 1,000,000 @ $1.52 | EDGAR |
| 2025-09-12 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Capital GP V LLC — 10% owner | Sale (S): 500,000 @ $1.80 | EDGAR |
| 2025-07-03 | 4 | Jalota Deepika — Chief Development Officer | Sale (S): 33,065 @ $1.06 | EDGAR |
| 2025-07-03 | 4 | Carulli Michael — Chief Financial Officer | Sale (S): 28,249 @ $1.06 | EDGAR |
| 2025-07-03 | 4 | Ticktin Robert — General Counsel & COO | Sale (S): 23,151 @ $1.06 | EDGAR |
| 2025-07-03 | 4 | Mack David Henry — President and CEO, Director | Sale (S): 58,411 @ $1.06 | EDGAR |
| 2025-06-09 | 4 | FLOWERS KIRSTEN — Director | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Stelzer Laurie — Director | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Heyman Richard A. — Director | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | BAUM CHARLES M — Director | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Gallagher Carol Giltner — Director | Grant/award (A): 33,500 (derivative) @ $0 · Gift (G): 33,500 (derivative) @ $0 · Gift (G): 33,500 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | LEVINE ARNOLD J — Director | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Carulli Michael — Chief Financial Officer | Grant/award (A): 265,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Jalota Deepika — Chief Development Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Mack David Henry — President and CEO, Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — PMV Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-10 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-09 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PMVP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →